心脏x综合征患者临床特征及治疗效果的病例报告(2)
[4]Dollard J， Kearney P， Clarke G， et al. A prospective study of C-reactive protein as a state marker in Cardiac Syndrome X[J].Brain， Behavior， and Immunity，2015，43：27-32.
[5]Ping Q， Luo SH， Guo YL，et al.Evaluation of Red Blood Cell Distribution Width in Patients with Cardiac Syndrome X[J].DISEASE MARKERS，2013，34(5)：333.
[6]Masoudkabir F，Vasheghani-Farahani A， Hakki E， et al. Novel Scoring System for Prediction of Cardiac Syndrome X in Women with Typical Angina and a Positive Exercise Tolerance Test[J].TEXAS HEART INSTITUTE JOURNAL，2018，45(1)：5-10.
[7]Ong P， Athanasiadis A，Sechtem U. Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction[J].CARDIOVASCULAR DRUGS AND THERAPY，2016，30(4)：351-356.
[8]Majidiniaa M， Rasmia Y，Ansaria MHK，et al. Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X[J].Iranian Journal of Pharmaceutical Research Ijpr，2016，15(3)：561-566.
[9]Kayaalt? F，Kalay N，Basar E， et al. Effects of nebivolol therapy on endothelial functions in cardiac syndrome X[J].HEART AND VESSELS，2010，25(2)：92-96.
[10]Andishmand A，Ansari Z，Soltani MH， et al. Vitamin D replacement therapy in patients with cardiac syndrome X[J].Perfusion，2014，30(1)：60-63.
[11]李 磊，刘建勋，任建勋，等.冠状动脉微循环功能障碍动物模型及中医药防治研究進展[J]. 中国中药杂志，2017，(02)：254-258.
本文编辑：吴宏艳, 百拇医药(苏停停 张勇 王怀根 王东琦)
[5]Ping Q， Luo SH， Guo YL，et al.Evaluation of Red Blood Cell Distribution Width in Patients with Cardiac Syndrome X[J].DISEASE MARKERS，2013，34(5)：333.
[6]Masoudkabir F，Vasheghani-Farahani A， Hakki E， et al. Novel Scoring System for Prediction of Cardiac Syndrome X in Women with Typical Angina and a Positive Exercise Tolerance Test[J].TEXAS HEART INSTITUTE JOURNAL，2018，45(1)：5-10.
[7]Ong P， Athanasiadis A，Sechtem U. Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction[J].CARDIOVASCULAR DRUGS AND THERAPY，2016，30(4)：351-356.
[8]Majidiniaa M， Rasmia Y，Ansaria MHK，et al. Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X[J].Iranian Journal of Pharmaceutical Research Ijpr，2016，15(3)：561-566.
[9]Kayaalt? F，Kalay N，Basar E， et al. Effects of nebivolol therapy on endothelial functions in cardiac syndrome X[J].HEART AND VESSELS，2010，25(2)：92-96.
[10]Andishmand A，Ansari Z，Soltani MH， et al. Vitamin D replacement therapy in patients with cardiac syndrome X[J].Perfusion，2014，30(1)：60-63.
[11]李 磊，刘建勋，任建勋，等.冠状动脉微循环功能障碍动物模型及中医药防治研究進展[J]. 中国中药杂志，2017，(02)：254-258.
本文编辑：吴宏艳, 百拇医药(苏停停 张勇 王怀根 王东琦)